D. Demanes

发表

American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.

C. Kirisits, B. Thomadsen, D. Gaffney, 2012, Brachytherapy.

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy.

J. Pouliot, I. Hsu, Y. Yamada, 2012, Brachytherapy.

American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer.

J. Rownd, R. Cormack, C. Yashar, 2012, Brachytherapy.

Multiparametric MRI identifies and stratifies prostate cancer lesions: implications for targeting intraprostatic targets.

D. Margolis, P. Kupelian, R. Banerjee, 2014, Brachytherapy.

American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy.

P. Devlin, D. O’Farrell, T. Delaney, 2013, Brachytherapy.

Brachytherapy of the head and neck: An University of California Los Angeles guide to morbidity reduction.

D. Demanes, P. Venkat, James Han, 2021, Brachytherapy.

Head and Neck Brachytherapy

D. Demanes, 2017 .

Head and Neck Brachytherapy: A Description of Methods and a Summary of Results

D. Demanes, 2016 .

Hormone receptors in hepatoblastoma: A demonstration of both estrogen and progesterone receptors

J. McKerrow, D. Demanes, M. Friedman, 1982, Cancer.

Outcomes of Node-positive Breast Cancer Patients Treated With Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience

Peter Y. Chen, M. Kamrava, D. Demanes, 2016, American journal of clinical oncology.

Locoregional recurrence by molecular subtype after multicatheter interstitial accelerated partial breast irradiation: Results from the Pooled Registry Of Multicatheter Interstitial Sites research group.

Peter Y. Chen, M. Kamrava, D. Demanes, 2016, Brachytherapy.

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.

G. Gustafson, C. Vargas, Jose A Gonzalez, 2005, International journal of radiation oncology, biology, physics.

Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features

A. Kishan, A. D'Amico, B. Trock, 2021, JAMA network open.

Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification

M. Kamrava, L. Marks, D. Demanes, 2016, American journal of clinical oncology.

American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer.

B. Amendola, L. Kim, S. Beriwal, 2017, Brachytherapy.

Bone involvement in Hairy‐cell leukemia

D. Demanes, J. Beckstead, Nancy Lane, 1982, Cancer.

Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors

J. Caprioli, Eun-Ah Kim, M. Kamrava, 2016, Journal of glaucoma.

Brachytherapy catheter spacing and stabilization technique.

M. Steinberg, Sang-June Park, J. Friedman, 2012, Brachytherapy.

The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy.

B. Erickson, F. Mourtada, N. Bittner, 2017, Brachytherapy.

High-dose-rate brachytherapy monotherapy without androgen deprivation therapy for intermediate-risk prostate cancer.

A. Pantuck, M. Steinberg, Sang-June Park, 2017, Brachytherapy.

High-Dose-Rate Monotherapy for Localized Prostate Cancer: 10-Year Results.

M. Steinberg, Sang-June Park, H. Hauswald, 2016, International journal of radiation oncology, biology, physics.

American College of Radiology-American Brachytherapy Society practice parameter for electronically generated low-energy radiation sources.

S. Nag, J. Petit, Ivan Buzurovic, 2017, Brachytherapy.

Survival in lung cancer.

D. Demanes, R. Parker, D. Rickles, 1978, The Western journal of medicine.

High Dose Rate Monotherapy for Prostate Cancer

L. Schour, D. Demanes, G. Altieri, 2005 .

A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy

J. Hegde, M. Steinberg, P. Kupelian, 2016, American Journal of Clinical Oncology.

Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma.

N. Agazaryan, M. Kamrava, D. Demanes, 2012, Ophthalmology.

Comment on "Medical use of all high activity sources should be eliminated for security concerns" [Med. Phys. 42, 6773-6775 (2015)].

Sang-June Park, Percy Lee, D. Demanes, 2016, Medical physics.

Brachytherapy: Where Has It Gone…Again?

M. Kamrava, D. Demanes, O. Ragab, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pre-Treatment MRI Staging Predicts for Biochemical Failure in High-Risk Prostate Cancer Treated with Combination High-Dose-Rate Brachytherapy and External Beam Radiotherapy

J. Hegde, Sang-June Park, M. Kamrava, 2017 .

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.

S Nag, B Vikram, B. Vikram, 2001, International journal of radiation oncology, biology, physics.

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer

A. Kishan, B. Trock, P. Boutros, 2021, JAMA network open.

American Brachytherapy Society-Groupe Européen de Curiethérapie-European Society of Therapeutic Radiation Oncology (ABS-GEC-ESTRO) consensus statement for penile brachytherapy.

C. Haie-meder, J. Crook, M. Rivard, 2013, Brachytherapy.

A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update.

Marco Zaider, Mark K Buyyounouski, P. Grimm, 2012, Brachytherapy.

Excellent Results From High Dose Rate Brachytherapy and External Beam for Prostate Cancer are Not Improved by Androgen Deprivation

L. Schour, D. Demanes, D. R. Hill, 2009, American journal of clinical oncology.

SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer.

A. Kishan, M. Steinberg, P. Kupelian, 2016, Practical radiation oncology.

High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.

L. Schour, D. Demanes, R. Rodriguez, 2005, International journal of radiation oncology, biology, physics.

American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy.

J. Rownd, W. Small, K. Dusenbery, 2012, Brachytherapy.

Hepatomas: hormone receptors and therapy.

D. Demanes, M. Friedman, P. G. Hoffman, 1982, The American journal of medicine.

Behçet's disease: a case with hemoptysis, pseudotumor cerbri, and arteritis.

D. Demanes, M. Reza, 1978, The Journal of rheumatology.

Head and neck cancer reirradiation with interstitial high‐dose‐rate brachytherapy

J. Hegde, Sang-June Park, M. Kamrava, 2018, Head & neck.

Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.

A. Kishan, S. Raman, J. Hegde, 2017, Brachytherapy.

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer

A. Kishan, A. D'Amico, D. Song, 2018, JAMA.

American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy.

I. Hsu, B. Erickson, G. Ibbott, 2011, International journal of radiation oncology, biology, physics.

Ureteral stent insertion for gynecologic interstitial high-dose-rate brachytherapy.

M. Steinberg, Sang-June Park, R. Banerjee, 2015, Brachytherapy.

Title Ureteral stent insertion for gynecologic interstitial high-dose-rate brachytherapy

M. Steinberg, Sang-June Park, R. Banerjee, 2014 .

Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study.

Todd McNutt, Ahmad Sadeghi, Patrick A Kupelian, 2017, International journal of radiation oncology, biology, physics.

Measurement of blood levels of prostate-specific antigen (PSA) and greater awareness have led to the detection of prostate cancer at an earlier and potentially more curable stage. As certain kinds of prostate

D. Demanes, 2009 .

High dose rate transperineal interstitial brachytherapy for cervical cancer: high pelvic control and low complication rates.

D. Demanes, R. Rodriguez, T. Ewing, 1999, International journal of radiation oncology, biology, physics.

Comparison of patient‐reported acute urinary and sexual toxicity scores in a 6‐ versus 2‐fraction course of high‐dose‐rate prostate brachytherapy monotherapy

Sang-June Park, R. Banerjee, M. Kamrava, 2018, Journal of medical imaging and radiation oncology.

A sector-based dosimetric analysis of dose heterogeneity in high-dose-rate prostate brachytherapy.

A. Kishan, Sang-June Park, M. Kamrava, 2015, Brachytherapy.

High-dose-rate brachytherapy as monotherapy for prostate cancer.

M. Ghilezan, D. Demanes, D Jeffrey Demanes, 2014, Brachytherapy.

Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment.

M. Steinberg, P. Kupelian, Sang-June Park, 2013, Brachytherapy.

Title Focal high-dose-rate brachytherapy : A dosimetric comparison of hemigland vs . conventional whole-gland treatment Permalink

M. Steinberg, P. Kupelian, Sang-June Park, 2022 .

High Dose Rate Brachytherapy (HDR-BT) as Monotherapy for Favorable Prostate Cancer: Excellent 5-Year Control Rates and Low Toxicity

G. Gustafson, I. Bernstein, L. Schour, 2007 .

Quantitative multiparametric MRI in uveal melanoma: increased tumor permeability may predict monosomy 3

Pin-Chieh Wang, B. Ellingson, M. Kamrava, 2015, Neuroradiology.

High dose rate prostate brachytherapy: the California Endocurietherapy (CET) method.

D. Demanes, R. Rodriguez, G. Altieri, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.

A. Kishan, M. Steinberg, P. Kupelian, 2017, International journal of radiation oncology, biology, physics.

Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.

Sang-June Park, M. Kamrava, Chenyang Wang, 2017, Brachytherapy.

Long term results from a prospective database on high dose rate (HDR) interstitial brachytherapy for primary cervical carcinoma.

M. Steinberg, M. Kamrava, D. Demanes, 2016, Gynecologic oncology.

Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.

A. Kishan, E. Horwitz, W. Aronson, 2017, European urology.

Ten-year outcomes for prostate cancer patients with Gleason 8 through 10 treated with external beam radiation and high-dose-rate brachytherapy boost in the PSA era

R. Galalae, H. Ye, C. Shah, 2016, Journal of Radiation Oncology.

Assessment of external beam radiation technology for dose escalation and normal tissue protection in the treatment of prostate cancer.

L. Potters, L. Verhey, M. Steinberg, 2008, International journal of radiation oncology, biology, physics.

Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer

P. Kupelian, M. Kamrava, D. Demanes, 2013, Prostate Cancer.

Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer

M. Steinberg, J. Rwigema, R. Banerjee, 2013, Journal of contemporary brachytherapy.

Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.

M. Steinberg, Sang-June Park, R. Banerjee, 2013, International journal of radiation oncology, biology, physics.

Radiotherapy versus radical prostatectomy for Gleason score 9-10 prostate adenocarcinoma: A multi-institutional comparative analysis of 1001 patients treated in the modern era.

A. Kishan, G. Merrick, J. Ciezki, 2017 .

An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate.

T. Mate, G. Gustafson, S. Nag, 2002, International journal of radiation oncology, biology, physics.

Electronic brachytherapy for postsurgical adjuvant vaginal cuff irradiation therapy in endometrial and cervical cancer: a retrospective study.

J. DeMarco, M. Steinberg, Sang-June Park, 2013, Brachytherapy.

Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer

A. Kishan, P. Boutros, D. Song, 2022, JAMA oncology.

American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer.

L. Potters, S. Nag, D. Beyer, 2011, International journal of radiation oncology, biology, physics.

High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer.

G. Gustafson, M. Ghilezan, L. Schour, 2011, International journal of radiation oncology, biology, physics.

Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.

A. Kishan, A. D'Amico, D. Song, 2020, European urology.

From whole gland to hemigland to ultra-focal high-dose-rate prostate brachytherapy: A dosimetric analysis.

Sang-June Park, R. Banerjee, M. Kamrava, 2015, Brachytherapy.

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

M. Zelefsky, M. Keyes, É. Vigneault, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A critical ACR appropriateness Criteria omission.

D. Demanes, L. Rogers, J. Hayes, 2014, Brachytherapy.

High-dose-rate prostate brachytherapy consistently results in high quality dosimetry.

J. DeMarco, M. Steinberg, Sang-June Park, 2013, International journal of radiation oncology, biology, physics.

Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.

A. Kishan, P. Boutros, D. Song, 2021, European urology.

Image-guided high-dose-rate brachytherapy: preliminary outcomes and toxicity of a joint interventional radiology and radiation oncology technique for achieving local control in challenging cases

A. Kishan, J. McWilliams, M. Kamrava, 2015, Journal of contemporary brachytherapy.

Is High-Dose-Rate Monotherapy Suitable for Selected Cases of High-Risk Localized Prostate Cancer?

Sang-June Park, H. Hauswald, M. Kamrava, 2015 .

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American Society for Radiation Oncology

S. Nag, J. Williamson, J. Welsh, 2011, Practical radiation oncology.

10-year Results in 1577 Intermediate/High Risk Prostate Cancer Patients Treated With External Beam RT (EBRT) and Hypofractionated High Dose Rate (HDR) Brachytherapy Boost

G. Gustafson, Alvaro Martinez, R. Galalae, 2007 .

Bone involvement in Hairy‐cell leukemia

D. Demanes, J. Beckstead, Nancy Lane, 1982, Cancer.

The use and advantages of a multichannel vaginal cylinder in high-dose-rate brachytherapy.

T. Wong, D. Demanes, S. Rege, 1999, International journal of radiation oncology, biology, physics.

Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.

Sang-June Park, R. Banerjee, Percy Lee, 2015, Brachytherapy.

State of the Art Review High-dose-rate brachytherapy as monotherapy for prostate cancer

M. Ghilezan, D. Demanes, 2014 .

Evaluating the Utility of a Multi-Parametric MRI-Based Cancer Suspicion Score in Defining Brachytherapy Focal Therapy Targets for Prostate Cancer

D. Margolis, S. Raman, R. Banerjee, 2013 .

Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.

A. Kishan, E. Horwitz, W. Aronson, 2017, European urology.

Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.

Sang-June Park, M. Kamrava, D. Demanes, 2015, Brachytherapy.

Combination high-dose-rate brachytherapy and external beam radiation therapy for the treatment of primary vaginal cancer: 5-year results

D. Demanes, Y. Lieskovsky, 2004 .

Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy

M. Kamrava, D. Demanes, J. Lamb, 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy.

B. Erickson, G. Ibbott, J. Tward, 2011, International journal of radiation oncology, biology, physics.

Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer

A. Kishan, M. Steinberg, P. Kupelian, 2017, American journal of clinical oncology.